Shuttle Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Shuttle Pharmaceuticals Inc cash flow-to-debt ratio. Shuttle Pharmaceuticals Inc (SHPH) has a Cash Flow-to-Debt Ratio of -0.29x as of March 2026, meaning its operating cash flow of $-2.42 Million could theoretically repay 0% of its total liabilities ($8.46 Million) in one year. See financial flexibility index of Shuttle Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Shuttle Pharmaceuticals Inc (2017–2025)
Cash flow-to-debt ratio of Shuttle Pharmaceuticals Inc from 2017 to 2025. Historical debt coverage capacity for Shuttle Pharmaceuticals Inc across 8 annual periods. Also explore Shuttle Pharmaceuticals Inc annual equity growth to track the company's year-over-year net asset growth rate.
Shuttle Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2017–2025)
Shuttle Pharmaceuticals Inc cash flow-to-debt ratio by year from 2017 to 2025. Year-by-year debt coverage analysis for Shuttle Pharmaceuticals Inc. For the full cash flow conversion analysis, see SHPH operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.15x | $-9.48 Million | $8.22 Million | ▲ +71.7% |
| 2024 | -4.08x | $-7.33 Million | $1.80 Million | ▼ -38.5% |
| 2023 | -2.94x | $-5.58 Million | $1.90 Million | ▼ -6.0% |
| 2022 | -2.78x | $-2.71 Million | $975.68K | ▼ -2008.7% |
| 2021 | -0.13x | $-300.34K | $2.28 Million | ▼ -997.1% |
| 2020 | -0.01x | $-26.83K | $2.23 Million | ▲ +98.7% |
| 2018 | -0.95x | $-566.69K | $593.82K | ▼ -91.0% |
| 2017 | -0.50x | $-202.71K | $405.65K | — |